EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria

Jia Wang, Sunhee Lee iD

Pathogens · 2025

DOI: 10.3390/pathogens14050472 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2025. Verfasst von Jia Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Autophagy, Mycobacterium Infections, Nontuberculous, Nontuberculous Mycobacteria, Host-Pathogen Interactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, The National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontuberculous mycobacteria (NTMs) are increasingly being recognized as opportunistic pathogens in clinical practice because of their innate resistance to antimicrobial treatment and the widespread increase in multidrug-resistant strains on a global scale. NTMs pose a tremendous infection management challenge, especially in individuals with pre-existing lung conditions, as well as those who are immunocompromised. NTMs’ capability to evade or suppress the immune responses of their host is a key feature that makes them a cause of persistent chronic infection. Autophagy, an essential cellular defense mechanism that delivers and breaks down intracellular materials in lysosomes, protects the host from mycobacterial infection. Initial studies have revealed encouraging therapeutic strategies that augment endogenous autophagic mechanisms or block harmful host responses, thus having the potential to decrease intracellular mycobacterial infection, including that caused by multidrug-resistant strains. This review discusses how NTMs can evade autophagic mechanisms and considers the possibilities of using autophagy-inducing agents to develop novel therapeutic strategies to combat NTM infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyMycobacterium Infections, NontuberculousNontuberculous MycobacteriaHost-Pathogen InteractionsAnti-Bacterial AgentsHumansAnimals

Stichwörter der Autor:innen

Mycobacterium tuberculosisautophagyhost-directed therapiesmacrophagesnontuberculous mycobacteria

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

ORCID-Profile: Sunhee Lee

Förderung

  • NIAID NIH HHS
  • The National Institute of Allergy and Infectious Diseases
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Wang, J., & Lee, S. (2025). Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria. Pathogens. https://doi.org/10.3390/pathogens14050472

Vancouver

Wang J, Lee S. Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria. Pathogens. 2025. doi:10.3390/pathogens14050472

BibTeX
@article{Wang2025,
  author = {Wang, Jia and Lee, Sunhee},
  title = {Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14050472}
}
Kostenlos starten →